1.7(top 50%)
impact factor
1.2K(top 20%)
papers
29.3K(top 10%)
citations
74(top 10%)
h-index
1.8(top 50%)
impact factor
1.5K
all documents
31.1K
doc citations
108(top 10%)
g-index
Top Articles
# | Title | Journal | Year | Citations |
---|---|---|---|---|
1 | Haemostatic changes in pregnancy | Best Practice and Research in Clinical Haematology | 2003 | 658 |
2 | Diagnosis and management of iron-deficiency anaemia | Best Practice and Research in Clinical Haematology | 2005 | 337 |
3 | Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages | Best Practice and Research in Clinical Haematology | 2005 | 325 |
4 | LPI-labile plasma iron in iron overload | Best Practice and Research in Clinical Haematology | 2005 | 251 |
5 | Obstetric and gynaecological aspects of von Willebrand disease | Best Practice and Research in Clinical Haematology | 2001 | 217 |
6 | Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease | Best Practice and Research in Clinical Haematology | 2001 | 217 |
7 | Blood and bone marrow changes in malaria | Best Practice and Research in Clinical Haematology | 2000 | 204 |
8 | Neuroprotective features of mesenchymal stem cells | Best Practice and Research in Clinical Haematology | 2011 | 195 |
9 | Epidemiology of cancer-related venous thromboembolism | Best Practice and Research in Clinical Haematology | 2009 | 193 |
10 | Rituximab resistance | Best Practice and Research in Clinical Haematology | 2011 | 189 |
11 | Glucose-6-phosphate dehydrogenase deficiency | Best Practice and Research in Clinical Haematology | 2000 | 180 |
12 | Venous thromboembolism: Epidemiology and magnitude of the problem | Best Practice and Research in Clinical Haematology | 2012 | 176 |
13 | Fanconi anemia and the development of leukemia | Best Practice and Research in Clinical Haematology | 2014 | 166 |
14 | Endothelial cell function and thrombosis | Best Practice and Research in Clinical Haematology | 1999 | 162 |
15 | Clinical importance of cytogenetics in acute myeloid leukaemia | Best Practice and Research in Clinical Haematology | 2001 | 162 |
16 | Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation | Best Practice and Research in Clinical Haematology | 2001 | 155 |
17 | Genetic events in the pathogenesis of multiple myeloma | Best Practice and Research in Clinical Haematology | 2007 | 154 |
18 | Procoagulant mechanisms in tumour cells | Best Practice and Research in Clinical Haematology | 2009 | 146 |
19 | Transformation of follicular lymphoma | Best Practice and Research in Clinical Haematology | 2011 | 142 |
20 | Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management | Best Practice and Research in Clinical Haematology | 2001 | 141 |
21 | Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches | Best Practice and Research in Clinical Haematology | 2010 | 140 |
22 | The variant form of hairy-cell leukaemia | Best Practice and Research in Clinical Haematology | 2003 | 133 |
23 | Neurological aspects of multiple myeloma and related disorders | Best Practice and Research in Clinical Haematology | 2005 | 131 |
24 | Modification of iron regulation by the inflammatory response | Best Practice and Research in Clinical Haematology | 2005 | 129 |
25 | Update on MALT lymphomas | Best Practice and Research in Clinical Haematology | 2005 | 127 |
26 | Haematology in dengue and dengue haemorrhagic fever | Best Practice and Research in Clinical Haematology | 2000 | 126 |
27 | The coagulopathy of acute promyelocytic leukaemia revisited | Best Practice and Research in Clinical Haematology | 2009 | 126 |
28 | Vascular endothelium as ‘novel’ target of graft-versus-host disease | Best Practice and Research in Clinical Haematology | 2008 | 125 |
29 | The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia | Best Practice and Research in Clinical Haematology | 2001 | 124 |
30 | Bivalent direct thrombin inhibitors: hirudin and bivalirudin | Best Practice and Research in Clinical Haematology | 2004 | 123 |
31 | Molecular genetics of acute myeloid leukaemia | Best Practice and Research in Clinical Haematology | 2001 | 122 |
32 | Epidemiology of chronic myeloid leukaemia (CML) | Best Practice and Research in Clinical Haematology | 2009 | 119 |
33 | Venetoclax-based therapies for acute myeloid leukemia | Best Practice and Research in Clinical Haematology | 2019 | 113 |
34 | Red cell pyruvate kinase deficiency: from genetics to clinical manifestations | Best Practice and Research in Clinical Haematology | 2000 | 112 |
35 | Pathogen inactivation techniques | Best Practice and Research in Clinical Haematology | 2006 | 111 |
36 | Epidemiology of the plasma-cell disorders | Best Practice and Research in Clinical Haematology | 2007 | 109 |
37 | Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation | Best Practice and Research in Clinical Haematology | 2008 | 106 |
38 | Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells | Best Practice and Research in Clinical Haematology | 2007 | 105 |
39 | RH blood group system and molecular basis of Rh-deficiency | Best Practice and Research in Clinical Haematology | 1999 | 104 |
40 | Autoimmunity following haematopoietic stem-cell transplantation | Best Practice and Research in Clinical Haematology | 2007 | 103 |
41 | Immunophenotyping in multiple myeloma and related plasma cell disorders | Best Practice and Research in Clinical Haematology | 2010 | 101 |
42 | Triosephosphate isomerase deficiency: historical perspectives and molecular aspects | Best Practice and Research in Clinical Haematology | 2000 | 100 |
43 | Thrombosis associated with angiogenesis inhibitors | Best Practice and Research in Clinical Haematology | 2009 | 100 |
44 | Mesenchymal stem cells and autoimmune diseases | Best Practice and Research in Clinical Haematology | 2011 | 100 |
45 | Retinoic acid syndrome: manifestations, pathogenesis, and treatment | Best Practice and Research in Clinical Haematology | 2003 | 99 |
46 | The leukemic stem cell | Best Practice and Research in Clinical Haematology | 2007 | 99 |
47 | Diagnosis and manifestations of chronic graft-versus-host disease | Best Practice and Research in Clinical Haematology | 2008 | 96 |
48 | Microparticles, thrombosis and cancer | Best Practice and Research in Clinical Haematology | 2009 | 95 |
49 | The penetrance of hereditary hemochromatosis | Best Practice and Research in Clinical Haematology | 2005 | 92 |
50 | Treatment of relapsed or refractory acute promyelocytic leukemia | Best Practice and Research in Clinical Haematology | 2007 | 92 |